| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16K | — | — |
| R&D Expense | $5.3M | — | -43.1% |
| SG&A Expense | $6.2M | — | -12.4% |
| Operating Income | -$4.6M | — | +71.8% |
| Income Tax | $0 | — | — |
| Net Income | -$4.2M | — | +70.1% |
| EPS (Basic) | -$0.14 | — | +90.1% |
| EPS (Diluted) | -$0.14 | — | +90.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.9M | -45.6% | -73.6% |
| Current Assets | $14.8M | -36.5% | -67.3% |
| Total Assets | $38.2M | -25.3% | -53.8% |
| Current Liabilities | $14.3M | +2.1% | +33.0% |
| Total Liabilities | $35.7M | -21.8% | -20.6% |
| Stockholders' Equity | $2.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.5M | — | +46.8% |
| Investing Cash Flow | $114K | — | — |
| Financing Cash Flow | -$118K | — | +71.5% |
| -93.2% |